Tag archive for ‘Switzerland’
Chubb Hartford merger news - Swiss insurer Chubb offers to acquire The Hartford for $23.2bn
By businessnewstoday On Saturday, March 20th, 2021
0 Comments

Chubb Hartford merger : Swiss insurer offers to acquire The Hartford for $23.2bn

(adsbygoogle = window.adsbygoogle || []).push({}); Chubb Hartford merger : Swiss property and casualty insurance company Chubb has offered to acquire The Hartford Financial Services Group for $65 More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Wednesday, February 3rd, 2021
0 Comments

VectivBio begins phase 3 trial of apraglutide in short bowel syndrome

VectivBio has dosed the first patient in its phase 3 STARS clinical trial of its synthetic GLP-2 analog apraglutide in short bowel syndrome (SBS). The Swiss clinical-stage biotech company said that the STARS trial More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Wednesday, February 3rd, 2021
0 Comments

VectivBio begins phase 3 trial of apraglutide in short bowel syndrome

VectivBio has dosed the first patient in its phase 3 STARS clinical trial of its synthetic GLP-2 analog apraglutide in short bowel syndrome (SBS). The Swiss clinical-stage biotech company said that the STARS trial More...

By pharmanewsdaily On Sunday, December 20th, 2020
0 Comments

Swissmedic authorizes use of BNT162b2 Covid-19 vaccine from Pfizer, BioNTech

Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company BioNTech. The Swiss pharma regulator said that More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Sunday, December 20th, 2020
0 Comments

Swissmedic authorizes use of BNT162b2 Covid-19 vaccine from Pfizer, BioNTech

Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company BioNTech. The Swiss pharma regulator said that More...

By pharmanewsdaily On Friday, December 11th, 2020
0 Comments

Boehringer Ingelheim to acquire NBE-Therapeutics for €1.1bn

German pharma company Boehringer Ingelheim has signed a deal worth €1.18 billion to acquire NBE-Therapeutics, a clinical-stage Switzerland-based biotech company, focused on developing antibody-drug conjugates More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Friday, December 11th, 2020
0 Comments

Boehringer Ingelheim to acquire NBE-Therapeutics for €1.1bn

German pharma company Boehringer Ingelheim has signed a deal worth €1.18 billion to acquire NBE-Therapeutics, a clinical-stage Switzerland-based biotech company, focused on developing antibody-drug conjugates More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By businessnewstoday On Tuesday, November 24th, 2020
0 Comments

Elliott Advisors offers to take over Swiss food company Aryzta for CHF0.8 per share

Elliott Advisors (UK) has proposed to take over Swiss food company Aryzta for an indicative price of CHF 0.80 per share. According to Elliott Advisors (UK), the financing for the proposed deal is available and that More...

NEC acquisition of Avaloq
By Soujanya Ravi On Tuesday, October 6th, 2020
0 Comments

NEC to acquire Swiss fintech company Avaloq for $2.2bn

NEC acquisition of Avaloq : NEC Corporation, a Japanese IT and electronics company, has agreed to acquire Avaloq Group, a Swiss financial software company, for CHF 2.05 billion ($2.27 billion). Avaloq is a provider More...

By pharmanewsdaily On Sunday, October 4th, 2020
0 Comments

Novartis reports positive results for Aimovig in phase 2 episodic migraine trial

Novartis said that a five-year phase 2 clinical trial of migraine prevention drug Aimovig (erenumab-aooe) has delivered strong long-term safety and efficacy results in patients with episodic migraine (EM). The results More...